JAZZ PHARMACEUT. DL-,0001/ IE00B4Q5ZN47 /
| 2024-09-20 9:55:01 PM | Chg. -0.7400 | Volume | Bid9:59:59 PM | Ask9:59:52 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 98.5000EUR | -0.75% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 6.13 bill.EUR | - | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 131.5060 | 127.9350 | 256.8370 | 228.0500 | 169.6460 | ||||||
| Intangible Assets | 2,440.9770 | 2,195.0510 | 7,152.3280 | 5,794.4370 | 5,418.0390 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 3,908.6290 | 3,696.3330 | 9,687.3050 | 8,229.1150 | 7,957.9310 | ||||||
| Inventories | 78.6080 | 95.3960 | 1,072.7210 | 714.0610 | 597.0390 | ||||||
| Accounts Receivable | 355.9870 | 396.4900 | 563.3600 | 651.4930 | 705.7940 | ||||||
| Cash and Cash Equivalents | 637.3440 | 1,057.7690 | 591.4480 | 881.4820 | 1,506.3100 | ||||||
| Current Assets | 1,630.2680 | 2,839.5680 | 2,611.3340 | 2,606.1400 | 3,435.4280 | ||||||
| Total Assets | 5,538.8970 | 6,535.9010 | 12,298.6390 | 10,835.2550 | 11,393.3590 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 47.5450 | 26.9450 | 100.2980 | 90.7580 | 102.7500 | ||||||
| Long-term debt | 1,573.8700 | 1,848.5160 | 6,018.9430 | 5,693.3410 | 5,107.9880 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 2,427.9160 | 2,876.1560 | 8,333.4480 | 7,749.5210 | 7,656.3620 | ||||||
| Share Capital | .0060 | .0060 | .0060 | .0060 | .0060 | ||||||
| Total Equity | 3,110.9810 | 3,659.7450 | 3,965.1910 | 3,085.7340 | 3,736.9970 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 5,538.8970 | 6,535.9010 | 12,298.6390 | 10,835.2550 | 11,393.3590 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,161.7610 | 2,363.5670 | 3,094.2380 | 3,659.3740 | 3,834.2040 | ||||||
| Depreciation (total) | 354.8140 | 259.5800 | 525.7690 | 599.1690 | 608.2840 | ||||||
| Operating Result | 532.3740 | 378.0730 | 170.2780 | -65.5280 | 578.5800 | ||||||
| Interest Income | -72.2610 | -99.7070 | -278.7660 | -288.2420 | -289.4380 | ||||||
| Income Before Taxes | 454.3020 | 275.0950 | -112.8380 | -372.7840 | 297.9290 | ||||||
| Income Taxes | -73.2000 | 33.5000 | 216.1000 | -158.6000 | -119.9120 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 523.3670 | 238.6160 | -329.6680 | -224.0600 | 414.8320 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 776.4010 | 899.6480 | 778.5070 | 1,271.9770 | 1,092.0070 | ||||||
| Cash Flow from Investing Activities | -155.3000 | -1,007.6700 | -5,212.1430 | -446.2300 | -163.0620 | ||||||
| Cash Flow from Financing | -293.7450 | 528.0730 | 3,970.5220 | -529.4910 | -305.2540 | ||||||
| Decrease / Increase in Cash | 327.7220 | 420.4250 | -466.3210 | 290.0340 | 624.8280 | ||||||
| Employees | - | - | - | - | - | ||||||
